Retinal disease in mice lacking hypoxia-inducible transcription factor-2alpha

Invest Ophthalmol Vis Sci. 2005 Mar;46(3):1010-6. doi: 10.1167/iovs.04-0788.

Abstract

Purpose: To characterize ocular disease in HIF-2alpha-null mice.

Methods: Histologic, electroretinographic (ERG), and molecular studies were performed on samples obtained from age- and gender-matched HIF-2alpha-null (HIF-2alpha-KO), HIF-2alpha-heterozygous (HIF-2alpha-HET), and wild-type (WT) littermate mice.

Results: HIF-2alpha-KO mice exhibited marked thinning of the retina and abnormal retinal vasculature. The pathologic changes in HIF-2alpha-KO mice were associated with a virtual absence of postreceptor function. The expression of a surrogate marker for HIF-2alpha mRNA localized to vascular endothelial, amacrine, and retinal pigment epithelial (RPE) cells. Several HIF-2alpha target genes involved in angiogenesis, retinal protection, and stress responses have altered expression patterns in HIF-2alpha-KO retinas.

Conclusions: HIF-2alpha-KO mice exhibit marked retinopathy consistent with complete loss of vision by 1 month of age. Impaired HIF-2alpha signaling in HIF-2alpha-KO mice likely produces functional deficits in cell types in which HIF-2alpha normally is expressed, ultimately resulting in retinopathy. Future studies will address whether the molecular abnormalities described in this study are directly responsible for the retinal disease in HIF-2alpha-KO mice.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Basic Helix-Loop-Helix Transcription Factors
  • Electroretinography
  • Female
  • Gene Deletion
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Motor Activity
  • Retina / physiology
  • Retinal Diseases / etiology*
  • Retinal Diseases / genetics
  • Retinal Diseases / physiopathology*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Trans-Activators / deficiency*
  • Trans-Activators / genetics
  • Vision Disorders / etiology
  • Vision Disorders / physiopathology

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • Trans-Activators
  • endothelial PAS domain-containing protein 1